
About Me
Javier Zulueta, MD is Senior Faculty and Chief of the Division of Medicine (Pulmonary, Critical Care and Sleep Medicine) at Mount Sinai Morningside.
Dr. Zulueta received his medical degree from Universidad Complutense de Madrid and completed his Internal Medicine residency training at St. Vincent Charity Medical Center Program. He did his fellowship in Pulmonary and Critical Care at Tufts Medical Center.
Please read his latest article "Lung Cancer Screening: It Might Just Save Your Life" in the Our Town syndicated newspapers.
Language
English
Position
ADJUNCT PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
Clinical Focus
- Bronchoscopy, Diagnostic
- Enlarged Lymph Nodes
- Lung Cancer
- Lung Mass
- Lung Nodule
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Zulueta during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Median Technologies
- DisitBiotech
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- HeartLung Technologies
Founder/Co-Founder/Partner
- Oncoswab Co
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.